Latest Period
Q2 2026
Security Snapshot
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) Institutional Ownership
CUSIP: 641288105
13F Institutional Holders and Ownership History from Q2 2021 to Q2 2026
Institutions Reporting
113
Shares (Excl. Options)
26,576,749
Price
$15.89
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- NPCE on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 26,576,749
- Total 13F value
- $422,386,883
- Portfolio coverage rank
- 0%
- Share change
- +109,180
- Value change
- +$2,981,885
- Number of holders
- 113
- Shares outstanding
- 34,207,386
- SEC-reported price per share
- $17.11
- Insider filing price
- $17.11
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share is tracked under CUSIP 641288105.
- 113 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 113 to 113 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $347,860,387 to $422,386,883.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 113 institutions filings for Q2 2026.
Security key
641288105
Latest holder period
Q2 2026
13F holders
113
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
NPCE full holder history
NeuroPace Inc SEC filings
NeuroPace Inc company facts
NeuroPace Inc insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 641288105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
NPCE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 9.1% | $34,534,675 | 2,972,003 | Polar Capital Holdings Plc | 31 Mar 2025 | |||
| Soleus Private Equity Fund I, L.P. | 8.9% | $30,496,537 | 2,957,957 | Guy Levy | 30 Sep 2025 | |||
| First Light Asset Management, LLC | 8.7% | $38,863,812 | 2,955,423 | Mathew P. Arens | 31 Mar 2026 | |||
| MORGAN STANLEY | 8.3% | $28,926,723 | 2,489,391 | Morgan Stanley | 31 Dec 2024 | |||
| Soleus Capital Master Fund, L.P. | 7% | $23,545,122 | 2,303,828 | Soleus Capital Management, L.P. | 30 Jun 2025 | |||
| ORBIMED ADVISORS LLC | 4.4% | -30% | $25,752,689 | -$10,118,888 | 1,505,125 | -28% | OrbiMed Advisors LLC | 30 Jun 2026 |
| Kent Lake PR LLC | 4.9% | -2% | $17,227,289 | +$116,944 | 1,482,555 | +0.68% | Kent Lake PR LLC | 31 Dec 2024 |
As of 30 Jun 2026, 113 institutional investors reported holding 26,576,749 shares of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE). This represents 78% of the company’s total 34,207,386 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
71%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 9.6% | 3,298,104 | 0% | 0.15% | $52,406,873 |
| Soleus Capital Management, L.P. | 8.5% | 2,911,122 | -0.72% | 1.6% | $46,257,729 |
| First Light Asset Management, LLC | 8.4% | 2,861,167 | +16% | 2.8% | $45,463,944 |
| MORGAN STANLEY | 7.8% | 2,654,391 | +3.4% | 0% | $42,178,273 |
| BlackRock, Inc. | 7.2% | 2,477,603 | +5.6% | 0% | $39,369,112 |
| ORBIMED ADVISORS LLC | 4.4% | 1,505,125 | -28% | 0.45% | $23,916,436 |
| Driehaus Capital Management LLC | 4.2% | 1,447,391 | -0.29% | 0.13% | $22,999,043 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 1,227,072 | +9.2% | 0% | $19,498,174 |
| DEUTSCHE BANK AG\ | 2.7% | 938,919 | +0.73% | 0% | $14,919,423 |
| ARMISTICE CAPITAL, LLC | 2% | 692,000 | 0% | 0.3% | $10,995,880 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 666,300 | +7.8% | 0% | $10,589,998 |
| FMR LLC | 1.6% | 554,771 | +0.22% | 0% | $8,815,311 |
| STATE STREET CORP | 1.6% | 550,132 | +11% | 0% | $8,741,597 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1% | 344,124 | -4.4% | 0.04% | $5,468,130 |
| NORTHERN TRUST CORP | 0.76% | 260,025 | +8.4% | 0% | $4,131,798 |
| Qube Research & Technologies Ltd | 0.65% | 221,237 | +19% | 0% | $3,515,456 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.64% | 220,371 | +18% | 0% | $3,501,695 |
| Palumbo Wealth Management LLC | 0.61% | 209,199 | -0.6% | 0.7% | $3,324,173 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.61% | 208,703 | -4.1% | 0.43% | $3,316,291 |
| ALGERT GLOBAL LLC | 0.54% | 184,774 | +2.9% | 0.03% | $2,936,059 |
| VANGUARD FIDUCIARY TRUST CO | 0.53% | 182,534 | +2.2% | 0% | $2,900,465 |
| JPMORGAN CHASE & CO | 0.51% | 173,311 | +23% | 0% | $2,864,831 |
| HighMark Wealth Management LLC | 0.48% | 163,000 | +159% | 0.87% | $2,590,070 |
| Russell Investments Group, Ltd. | 0.47% | 162,164 | -9.4% | 0% | $2,576,783 |
| D. E. Shaw & Co., Inc. | 0.47% | 161,081 | +269% | 0% | $2,559,577 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q2 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 26,576,749 | $422,386,883 | +$2,981,885 | $15.89 | 113 |
| 2026 Q1 | 26,457,206 | $347,860,387 | +$8,130,556 | $13.15 | 113 |
| 2025 Q4 | 26,299,826 | $405,917,159 | +$12,534,292 | $15.44 | 100 |
| 2025 Q3 | 25,945,404 | $267,500,978 | +$34,175,646 | $10.31 | 80 |
| 2025 Q2 | 22,505,448 | $250,711,399 | -$19,749,912 | $11.14 | 98 |
| 2025 Q1 | 23,932,784 | $294,127,661 | +$42,108,506 | $12.29 | 89 |
| 2024 Q4 | 20,868,828 | $233,522,000 | +$8,990,314 | $11.19 | 61 |
| 2024 Q3 | 14,795,861 | $103,125,040 | +$1,471,249 | $6.97 | 48 |
| 2024 Q2 | 14,430,601 | $109,095,635 | +$4,457,712 | $7.56 | 51 |
| 2024 Q1 | 13,364,973 | $176,414,273 | +$9,053,052 | $13.20 | 53 |
| 2023 Q4 | 12,690,314 | $130,836,764 | +$2,444,618 | $10.31 | 41 |
| 2023 Q3 | 18,073,997 | $175,859,892 | +$5,454,271 | $9.73 | 24 |
| 2023 Q2 | 17,503,080 | $78,589,150 | -$756,243 | $4.49 | 20 |
| 2023 Q1 | 17,670,188 | $81,990,736 | +$1,754,483 | $4.64 | 24 |
| 2022 Q4 | 17,357,024 | $25,862,002 | -$2,680,436 | $1.49 | 22 |
| 2022 Q3 | 18,161,017 | $68,102,000 | -$1,024,177 | $3.75 | 27 |
| 2022 Q2 | 18,426,044 | $91,207,000 | -$26,340 | $4.95 | 26 |
| 2022 Q1 | 18,210,639 | $149,512,180 | -$117,404 | $8.21 | 37 |
| 2021 Q4 | 18,012,051 | $181,543,000 | +$1,949,052 | $10.08 | 41 |
| 2021 Q3 | 11,190,051 | $177,393,000 | +$509,015 | $15.85 | 39 |
| 2021 Q2 | 10,905,701 | $259,451,000 | +$259,451,000 | $23.79 | 44 |